Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes

N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes

US Patent 8148413 · Granted Apr 3, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Serotonin 5-HT2B inhibitory compounds2025
Serotonin 5-HT2B inhibitory compounds2025
Amylin receptor agonists2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2024
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2024
Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-2024
Metabolites of [3-(4-(2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl)-2024
Compounds for treatment of obesity2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and method2023